CaptureSelect™ Biotin Anti-FVII Conjugate

CaptureSelect Biotin Anti-FVII Conjugate consists of a 13 kDa recombinant single domain antibody fragment (V_HH affinity ligand) that specifically binds with high affinity and selectivity to both recombinant and plasma-derived human factor VII as well as its activated form (FVIIa). The affinity ligand is chemically conjugated to biotin via an appropriate spacer that retains the binding reactivity of the ligand when used in combination with streptavidin-based conjugates or streptavidin pre-coated surfaces. This conjugate allows you to detect, quantitate, and characterize recombinant and plasma-derived human FVII.

Applications for CaptureSelect Biotin Anti-FVII Conjugate include ELISA, Gyrolab™-based immunoassays, and label-free detection platforms such as those based on surface plasmon resonance (Biacore™ and IBIS-MX96 systems) and bio-layer interferometry (ForteBio™ Octet™ systems).

Animal origin statement

CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (V_HH) created by a proprietary technology. The V_HH affinity ligand is a 12–15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (Animal Origin-Free).